423 related articles for article (PubMed ID: 18724067)
1. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
Vignesh R; Shankar EM; Murugavel KG; Kumarasamy N; Sekar R; Irene P; Solomon S; Balakrishnan P
Nephron Clin Pract; 2008; 110(1):c55-7. PubMed ID: 18724067
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
5. Increasing in vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
[No Abstract] [Full Text] [Related]
6. In vitro resistance of E coli to TMP/SMX and clinical failure.
Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
[No Abstract] [Full Text] [Related]
7. Clinical implications. In vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
[No Abstract] [Full Text] [Related]
8. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
9. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
10. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?
Mangin D; Toop L; Chambers S; Ikram R; Harris B
N Z Med J; 2005 Nov; 118(1225):U1726. PubMed ID: 16286940
[TBL] [Abstract][Full Text] [Related]
11. The role of clinical guidelines.
Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
[No Abstract] [Full Text] [Related]
12. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
13. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.
Butler CC; Hillier S; Roberts Z; Dunstan F; Howard A; Palmer S
Br J Gen Pract; 2006 Sep; 56(530):686-92. PubMed ID: 16954001
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.
Falagas ME; Polemis M; Alexiou VG; Marini-Mastrogiannaki A; Kremastinou J; Vatopoulos AC
Med Sci Monit; 2008 Feb; 14(2):CR75-79. PubMed ID: 18227764
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
19. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections.
Kahlmeter G; Menday P
J Antimicrob Chemother; 2003 Jul; 52(1):128-31. PubMed ID: 12805266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
